WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC – Ligand Pharmaceuticals Incorporated Transaction History
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC portfolio value:
$35.91M
portfolio value
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC quarter portfolio value change:
-3.49%
quarter
Ligand Pharmaceuticals Incorporated 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +5.31% | 21.03K shares | 579K | $86.11 | 417.07K |
| Q2 2022 | share | Decrease | -56.67% | -518.05K shares | -67.49M | $89.22 | 396.04K |
| Q1 2022 | share | Decrease | -34.72% | -486.24K shares | -113.47M | $112.49 | 914.09K |
| Q4 2021 | share | Increase | +1.77% | 24.4K shares | 24.60M | $156.16 | 1.40M |
| Q3 2021 | share | Increase | +10.39% | 129.48K shares | 28.17M | $139.32 | 1.37M |
| Q2 2021 | share | Decrease | -3.47% | -44.80K shares | -33.33M | $131.19 | 1.24M |
| Q1 2021 | share | Decrease | -36.74% | -749.79K shares | -6.13M | $152.45 | 1.29M |
| Q4 2020 | share | Increase | +7.69% | 145.67K shares | 22.31M | $99.45 | 2.04M |
| Q3 2020 | share | Increase | +27.51% | 408.87K shares | 14.40M | $95.32 | 1.89M |
| Q2 2020 | share | Decrease | -2.22% | -33.79K shares | 55.70M | $111.85 | 1.48M |
| Q1 2020 | share | Increase | +7.30% | 103.44K shares | -37.20M | $72.72 | 1.52M |
| Q4 2019 | share | Increase | +6.04% | 80.70K shares | 14.76M | $104.29 | 1.41M |
| Q3 2019 | share | Increase | +48.90% | 438.77K shares | 30.56M | $99.54 | 1.33M |
| Q2 2019 | share | Increase | +1.10% | 9.72K shares | -9.15M | $114.15 | 897.37K |
| Q1 2019 | share | Decrease | -9.17% | -89.64K shares | -21.03M | $125.71 | 887.64K |
| Q4 2018 | share | Decrease | -5.13% | -52.89K shares | -150.15M | $135.7 | 977.28K |
| Q3 2018 | share | Decrease | -9.40% | -106.83K shares | 47.21M | $274.49 | 1.03M |
| Q2 2018 | share | Increase | +10.48% | 107.9K shares | 65.58M | $207.17 | 1.13M |
| Q1 2018 | share | Decrease | -17.01% | -210.96K shares | 165K | $165.16 | 1.02M |
| Q4 2017 | share | Increase | +8.08% | 92.69K shares | 13.58M | $136.93 | 1.24M |
| Q3 2017 | share | Decrease | -35.30% | -626.05K shares | -59.08M | $136.15 | 1.14M |
| Q2 2017 | share | Increase | +2.62% | 45.25K shares | 32.38M | $121.4 | 1.77M |
| Q1 2017 | share | Increase | +42.28% | 513.53K shares | 59.49M | $105.84 | 1.72M |
| Q4 2016 | share | Increase | +23.58% | 231.73K shares | 23.10M | $101.61 | 1.21M |
| Q3 2016 | share | Decrease | -21.70% | -272.36K shares | -49.40M | $102.06 | 982.90K |
| Q2 2016 | share | Increase | +2.10% | 25.82K shares | 18.05M | $119.27 | 1.25M |
| Q1 2016 | share | Increase | +7.80% | 88.94K shares | 8.00M | $107.09 | 1.22M |